Annalisa La Cesa
- Oncology top 5%
- Bone health and treatments 8
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 6
-
- Radiopharmaceutical Chemistry and Applications 5
-
- Gastric Cancer Management and Outcomes 3
- Prostate Cancer Treatment and Research 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Giuseppe ToniniDaniele SantiniBruno VincenziNicoletta OnoriGiordano DicuonzoUmberto Vespasiani‐GentilucciAntonio PicardiSusanna Scarpa
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Annalisa La Cesa
23 papers receiving 642 citations
Peers
Comparison fields: 5 of 71
- Oncology 459
- Orthopedics and Sports Medicine 142
- Radiology, Nuclear Medicine and Imaging 117
- Rheumatology 70
- Pulmonary and Respiratory Medicine 142
Countries citing papers authored by Annalisa La Cesa
This map shows the geographic impact of Annalisa La Cesa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annalisa La Cesa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annalisa La Cesa more than expected).
Fields of papers citing papers by Annalisa La Cesa
This network shows the impact of papers produced by Annalisa La Cesa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annalisa La Cesa. The network helps show where Annalisa La Cesa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Annalisa La Cesa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 13 | |
| 2 | 2006 | 17 | |
| 3 | 2006 | 4 | |
| 4 | 2006 | 28 | |
| 5 | 2006 | 22 | |
| 6 | 2006 | 22 | |
| 7 | 2005 | 108 | |
| 8 | 2005 | 46 | |
| 9 | 2005 | 22 | |
| 10 | A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study. | 2005 | 5 |
| 11 | 2004 | 14 | |
| 12 | 2004 | 51 | |
| 13 | S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury. | 2004 | 32 |
| 14 | 2004 | 9 | |
| 15 | 2003 | 9 | |
| 16 | 2003 | 127 | |
| 17 | 2003 | 14 | |
| 18 | 2003 | 0 | |
| 19 | 2003 | 3 | |
| 20 | Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients. | 2003 | 54 |
About Annalisa La Cesa
Annalisa La Cesa is a scholar working on Oncology, Dermatology and Toxicology, having authored 24 papers that have together received 657 indexed citations. Recurring topics across this work include Bone health and treatments (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Gastric Cancer Management and Outcomes (3 papers), Prostate Cancer Treatment and Research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Oncology (459 citations), Orthopedics and Sports Medicine (142 citations) and Radiology, Nuclear Medicine and Imaging (117 citations). Annalisa La Cesa has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Giuseppe Tonini, Daniele Santini, Bruno Vincenzi, Nicoletta Onori, Giordano Dicuonzo, Umberto Vespasiani‐Gentilucci, Antonio Picardi, Susanna Scarpa, Laura Rocci and Fortunata Vasaturo. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.